Insiders HeraMED Limited

Equities

Market Closed - Australian S.E. Other stock markets 10:05:53 21/06/2024 am IST			5-day change	1st Jan Change
0.028 ^AUD	+3.70%		+64.71%	+16.67%

19/06	HeraMED's Registered Users on HeraCARE Platform Rise 12%; Shares Rally 33%	MT
17/06	HeraMED's Patient Monitoring Platform Goes Live in US	MT

HeraMED Appoints Auditor	20/05	MT
Heramed Limited Announces Board Changes	11/03	CI
HeraMED Limited Announces Emily Slade to Resign as Non-Executive Director	17/01	CI
HeraMED CEO Steps Down; CFO Transitions to EVP Role; Shares Surge 33%	08/11	MT
HeraMED Limited Limited Announces Resignation of David Groberman as Chief Executive Officer with Immediate Effect	08/11	CI
HeraMED Limited Announces Resignation of David Groberman as Managing Director	08/11	CI
HeraMED Transitions Chair to Executive Role	03/23/03	MT
Heramed Limited Announces Board Changes	20/23/20	CI
HeraMED Limited Announces Appointment of Keith Koby as President, North America	24/23/24	CI
HeraMED Limited Appoints Emily Slade as Non-Executive Director	13/22/13	CI
HMD Appoints Anoushka Gungadin as Director of Strategic Partnerships Australia and New Zealand	26/22/26	CI
HeraMED Limited Announces Change of Company Secretary; Announces Changes Registered Address	02/20/02	CI
HeraMED Appoints Alexander Radke as General Manager of US Operations	03/20/03	CI
HeraMED Limited Appoints Paul A. Friedman to Company's Advisory Board	20/19/20	CI
HeraMED Limited Appoints Arturo Weschler MD, as VP of Innovation	26/19/26	CI
HeraMED Limited Appoints Doron Birger as Director	11/18/11	CI
HeraMED Limited Appoints Ronald Weinberger as Director	11/18/11	CI
HeraMED Limited Appoints Tal Slonim as Director	11/18/11	CI
HeraMED Limited Appoints David Groberman as Director	11/18/11	CI
HeraMED Limited Appoints David Hinton as Director	11/18/11	CI

No results for this search